Circular No. 18/2018/TT-BYT amends and supplements some Articles of Circular No. 52/2017/TT-BYT dated December 29, 2017 on prescriptions and prescription of chemical drugs and biological products for outpatient treatment.

Circular No. 18/2018/TT-BYT amends and supplements some provisions of Circular No. 52/2017/TT-BYT on prescriptions and prescription of chemical drugs and biological products for outpatient treatment. This document aims to improve the prescription management process and ensure patient safety.

Số hiệu18/2018/TT-BYT
Loại văn bảnCircular
Cơ quan ban hànhMinistry of Health
Người kýNguyễn Việt Tiến — Thứ trưởng
Cập nhật13/06/2026
NgànhHealth
Ngày ban hành22/08/2018
Ngày áp dụng15/10/2018
Ngày hết hiệu lực01/07/2025
Tình trạngExpired
✦ Tóm lược thông minh

Circular No. 18/2018/TT-BYT amends and supplements some provisions of Circular No. 52/2017/TT-BYT on prescriptions and prescription of chemical drugs and biological products for outpatient treatment. This document aims to improve the prescription management process and ensure patient safety.

Đối tượng áp dụng

Medical examination and treatment facilities; relevant agencies and organizations

Các điểm cốt lõi

  • For children under 72 months old → record the age in months, weight, name of father or mother, or person bringing the child for medical examination (Article 6)
  • Doctors at medical examination and treatment facilities with inpatient beds → prescribe addictive drugs not exceeding 10 days' usage (Article 8)
  • Drug administration agency → notify the list of facilities issuing and selling addictive drugs to related medical examination and treatment facilities (Article 14)
  • Pharmacy department of hospitals without drug retail outlets → supply addictive drugs to outpatients at the purchase price (Article 14)
  • This circular amends the model prescription issued together with Circular No. 52/2017/TT-BYT

🌐 Tác động xã hội từ văn bản này

  • To ensure patient safety when using addictive drugs
  • Strengthen management and control over the prescription of addictive drugs
  • For medical examination and treatment facilities: additional responsibility for providing information on the list of facilities issuing and selling addictive drugs

❓ Câu hỏi thường gặp

How does this circular specifically regulate the prescription of addictive drugs?

Doctors at medical examination and treatment facilities with inpatient beds must prescribe addictive drugs not exceeding 10 days' usage (Article 8)

What does this circular stipulate regarding the notification of the list of facilities issuing and selling addictive drugs?

The drug administration agency must notify the list of facilities issuing and selling addictive drugs to related medical examination and treatment facilities (Article 14)

When does this circular take effect?

Circular No. 18/2018/TT-BYT takes effect from October 15, 2018

Toàn văn

CIRCULAR

AMENDMENTS AND SUPPLEMENTS TO SOME ARTICLES OF CIRCULAR NO. 52/2017/TT-BYT DATED DECEMBER 29, 2017 ON PRESCRIPTIONS AND MEDICATION RECIPTS FOR CHEMICAL DRUGS AND BIOPRODUCTS IN OUTPATIENT TREATMENT

Based on the Drug Law No. 105/2016/QH13 dated April 6, 2016;

Pursuant to Decree No. 75/2017/NĐ-CP dated June 20, 2017 of the Government stipulating the functions, tasks, powers, and organizational structure of the Ministry of Health;

At the proposal of the Director of the Department of Medical Examination and Treatment;

The Minister of Health issues this Circular to amend and supplement some Articles of Circular No. 52/2017/TT-BYT dated December 29, 2017 on prescriptions and medication receipts for chemical drugs and bioproducts in outpatient treatment.

Article 1. Amend and supplement some Articles of Circular No. 52/2017/TT-BYT dated December 29, 2017 on prescriptions and medication receipts for chemical drugs and bioproducts in outpatient treatment

1. Amend Clause 3 of Article 6 as follows:

“3. For children under 72 months old, record the age in months, weight, and the name of the child’s father or mother or the person bringing the child for medical examination and treatment.”

2. Amend the phrase “issued together with this Circular, along with a summary of the medical record according to Point c Clause 4 Article 59 of the Law on Medical Examination and Treatment, from the last medical facility providing treatment, to serve as a basis for doctors at medical facilities with hospital beds to prescribe medications; each prescription shall not exceed 10 (ten) days of usage” in Clause 2 of Article 8 as follows:

“issued together with this Circular (confirmed valid for one prescription), along with a summary of the medical record. The summary of the medical record shall be implemented according to the model of the summary of the medical record specified in Appendix 6 of Circular No. 14/2016/TT-BYT dated May 12, 2016 issued by the Minister of Health detailing the implementation of certain provisions of the Social Insurance Law in the field of health care.”

In cases where the last medical facility providing treatment prescribes medication for patients, there is no need for a summary of the medical record.

Prescribing addictive drugs must be done by doctors at medical facilities with hospital beds providing inpatient treatment, with the maximum quantity prescribed per prescription being 10 (ten) days of usage.”

3. Supplement Point c to Clause 2 of Article 14 as follows:

“c) Notify medical examination and treatment facilities, relevant agencies and units within the locality about the list of facilities issuing and selling addictive drugs.”

4. Supplement Point đ to Clause 3 of Article 14 as follows:

“đ) For districts, counties, towns, and cities directly under provinces that do not have facilities selling addictive drugs, the pharmacy department of hospitals must supply addictive drugs to outpatients in the locality at the purchase price of medical examination and treatment facilities according to the laws on drug pricing management to ensure sufficient drug supply for patients.”

5. Replace the Prescription Form specified in Appendix I issued together with Circular No. 52/2017/TT-BYT dated December 29, 2017 of the Minister of Health on prescriptions and medication receipts for chemical drugs and bioproducts in outpatient treatment with the Prescription Form issued together with this Circular.

Article 2. Effective Date

This Circular takes effect from October 15, 2018,

Article 3. Responsibility for Implementation

The Director of the Department of Medical Examination and Treatment, the Head of the Ministry's Office, the Inspector General of the Ministry, heads of subordinate units of the Ministry of Health, provincial/municipal health services directly under the central government, medical examination and treatment facilities, other related agencies, organizations, and individuals are responsible for implementing this Circular.

During the implementation process, if there are difficulties or obstacles, units and localities should report in writing to the Ministry of Health for consideration and resolution./.

 

Văn bản gốc (PDF)

Mở PDF trong tab mới ↗